| Date | Time | Source | Headline | Symbol | Company |
| 05/29/2007 | 4:47PM | Business Wire | Gilead Announces Achievement of Primary Efficacy Endpoint in Second Phase III Study of Aztreonam Lysine for Inhalation in Patien | NASDAQ:GILD | Gilead Sciences Inc |
| 05/22/2007 | 4:15PM | Business Wire | Gilead Sciences to Present at Bank of America's 2007 Healthcare Conference on Wednesday, May 30 | NASDAQ:GILD | Gilead Sciences Inc |
| 05/21/2007 | 12:45PM | Business Wire | Gilead Announces Presentation of Long-Term Data for Ambrisentan, a Potential Treatment for Patients With Pulmonary Arterial Hype | NASDAQ:GILD | Gilead Sciences Inc |
| 05/17/2007 | 4:15PM | Business Wire | Gilead Sciences' Chief Operating Officer and Chief Financial Officer Establishes Rule 10b5-1 Stock Trading Plan | NASDAQ:GILD | Gilead Sciences Inc |
| 05/17/2007 | 10:31AM | PR Newswire (US) | Seven Summits Research Releases Alerts on DELL, SHLD, AET, GILD, and COH | NASDAQ:GILD | Gilead Sciences Inc |
| 05/15/2007 | 4:15PM | Business Wire | Gilead Sciences to Present at Citigroup's 2007 Global Healthcare Conference on Wednesday, May 23 | NASDAQ:GILD | Gilead Sciences Inc |
| 05/10/2007 | 9:00AM | Business Wire | Gilead Sciences Announces Senior Management Promotion | NASDAQ:GILD | Gilead Sciences Inc |
| 05/08/2007 | 4:15PM | Business Wire | Gilead Board of Directors Approves Two-for-One Stock Split | NASDAQ:GILD | Gilead Sciences Inc |
| 04/25/2007 | 4:30PM | Business Wire | Gilead Sciences to Present at the Morgan Stanley Global Healthcare Unplugged Conference on Wednesday, May 2 | NASDAQ:GILD | Gilead Sciences Inc |
| 04/25/2007 | 10:31AM | PR Newswire (US) | Seven Summits Research Releases Alerts on EBAY, MER, GLW, GILD, and UNP | NASDAQ:GILD | Gilead Sciences Inc |
| 04/19/2007 | 4:05PM | Business Wire | Gilead Announces Presentation of Positive Phase III Data on Aztreonam Lysine for Inhalation in Patients With Cystic Fibrosis | NASDAQ:GILD | Gilead Sciences Inc |
| 04/18/2007 | 4:05PM | Business Wire | Gilead Sciences Announces First Quarter 2007 Financial Results | NASDAQ:GILD | Gilead Sciences Inc |
| 04/11/2007 | 4:30PM | Business Wire | Gilead Sciences to Release First Quarter 2007 Financial Results on Wednesday, April 18, 2007 | NASDAQ:GILD | Gilead Sciences Inc |
| 04/05/2007 | 4:30PM | Business Wire | Gilead Sciences to Present at the CIBC World Markets Annual Biotechnology & Specialty Pharmaceuticals Conference on Thursday, Ap | NASDAQ:GILD | Gilead Sciences Inc |
| 03/23/2007 | 9:00AM | Business Wire | Marketing Authorisation Application for Ambrisentan Validated by European Medicines Agency | NASDAQ:GILD | Gilead Sciences Inc |
| 03/20/2007 | 12:51PM | PR Newswire (US) | Seven Summits Research Releases Comments on F, SNDK, NOK, FCX, and GILD | NASDAQ:GILD | Gilead Sciences Inc |
| 03/15/2007 | 4:30PM | Business Wire | Gilead Sciences to Present at the Lehman Brothers 10th Annual Global Healthcare Conference on Monday, March 19 | NASDAQ:GILD | Gilead Sciences Inc |
| 03/15/2007 | 4:15PM | Business Wire | Data from Preclinical Studies of Gilead Nucleotide Compound GS 9219 to be Presented at AACR | NASDAQ:GILD | Gilead Sciences Inc |
| 03/09/2007 | 9:00AM | Business Wire | Gilead Sciences Announces New Appointments within Executive Team | NASDAQ:GILD | Gilead Sciences Inc |
| 03/08/2007 | 4:30PM | Business Wire | Gilead Sciences to Present at the Cowen & Company 27th Annual Health Care Conference on Monday, March 12 | NASDAQ:GILD | Gilead Sciences Inc |
| 03/01/2007 | 4:00PM | Business Wire | Gilead Announces 24-Week Results from Phase II Study of Investigational HIV Integrase Inhibitor GS 9137 | NASDAQ:GILD | Gilead Sciences Inc |
| 02/23/2007 | 4:00PM | Business Wire | Gilead Announces Completion of Phase II Clinical Trial of Novel Investigational HIV Integrase Inhibitor GS 9137 | NASDAQ:GILD | Gilead Sciences Inc |
| 02/08/2007 | 4:24PM | PR Newswire (US) | Gilead and Achillion Announce Positive Antiviral Activity of NS4A Antagonist in HCV, But Discontinue GS 9132 (ACH-806) Developme | NASDAQ:GILD | Gilead Sciences Inc |
| 02/01/2007 | 9:31AM | PR Newswire (US) | Seven Summits Research Releases Alerts on GOOG, ADM, GILD, PHM, and SIRF | NASDAQ:GILD | Gilead Sciences Inc |
| 01/31/2007 | 4:00PM | Business Wire | Gilead Sciences Announces Fourth Quarter and Full Year 2006 Financial Results | NASDAQ:GILD | Gilead Sciences Inc |
| 01/25/2007 | 5:00PM | Business Wire | Gilead Sciences Announces Senior Management Promotion | NASDAQ:GILD | Gilead Sciences Inc |
| 01/24/2007 | 4:30PM | Business Wire | Gilead Sciences to Release Fourth Quarter and Year End 2006 Financial Results on Wednesday, January 31, 2007 | NASDAQ:GILD | Gilead Sciences Inc |
| 01/23/2007 | 8:45AM | Business Wire | Carla A. Hills Joins Gilead Sciences' Board of Directors | NASDAQ:GILD | Gilead Sciences Inc |
| 01/04/2007 | 4:15PM | Business Wire | Gilead Sciences to Present at the 25th Annual JPMorgan Healthcare Conference on Monday, January 8th | NASDAQ:GILD | Gilead Sciences Inc |
| 12/22/2006 | 2:50PM | PR Newswire (US) | Invest Northwest 2007 Keynote Speakers to be Edward Fritzky and John Milligan | NASDAQ:GILD | Gilead Sciences Inc |